Search

everythinglearnresearchcommunity

for

Search:↓

The right cells and signals can potentially lead to scarless wound healing, with a mix of natural and external wound healing controllers possibly being the best way to achieve this.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Pine bark extract helps mice grow hair by reducing inflammation and boosting growth factors.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

17β-estradiol can reduce inflammation in the skin.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Some drugs used to treat inflammation may cause hair loss.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Astressin-B can reverse and prevent hair loss in stressed mice.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Targeting the actin cytoskeleton could improve skin healing and reduce scarring.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

NMN could potentially treat hair loss by reducing oxidative stress and improving cell health.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.